Wakamoto Pharmaceutical
4512.T
#10170
Rank
ยฃ47.36 M
Marketcap
ยฃ1.36
Share price
0.00%
Change (1 day)
-0.83%
Change (1 year)

Revenue for Wakamoto Pharmaceutical (4512.T)

Revenue in 2026 (TTM): ยฃ48.58 Million

According to Wakamoto Pharmaceutical's latest financial reports the company's current revenue (TTM ) is ยฃ49.29 Million. In 2025 the company made a revenue of ยฃ47.95 Million a decrease over the revenue in the year 2024 that were of ยฃ60.81 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Wakamoto Pharmaceutical from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ48.58 M1.31%
2025 ยฃ47.95 M-21.15%
2024 ยฃ60.81 M37.03%
2023 ยฃ44.38 M-15.11%
2022 ยฃ52.28 M-6.75%
2021 ยฃ56.06 M-11.08%
2020 ยฃ63.05 M-19.08%
2019 ยฃ77.92 M2.86%
2018 ยฃ75.75 M5.61%
2017 ยฃ71.73 M-12.67%
2016 ยฃ82.14 M31.6%
2015 ยฃ62.41 M-0.58%
2014 ยฃ62.78 M-1.32%
2013 ยฃ63.62 M-12.03%
2012 ยฃ72.31 M-7.81%
2011 ยฃ78.44 M10.15%
2010 ยฃ71.21 M10.33%
2009 ยฃ64.54 M